Dietary intake of glucoraphanin prevents the reduction of dopamine transporter in the mouse striatum after repeated administration of MPTP
Abstract Aims Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder. Although diet may influence the development of PD, the precise mechanisms underlying relationship between diet and PD pathology are unknown. Here, we examined whether dietary intake of glucoraphanin...
Main Authors: | Yaoyu Pu, Youge Qu, Lijia Chang, Si‐ming Wang, Kai Zhang, Yusuke Ushida, Hiroyuki Suganuma, Kenji Hashimoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Neuropsychopharmacology Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/npr2.12060 |
Similar Items
-
Dietary intake of glucoraphanin during pregnancy and lactation prevents the behavioral abnormalities in the offspring after maternal immune activation
by: Yuko Fujita, et al.
Published: (2020-09-01) -
Glucosinolate hydrolysis and bioavailability of resulting isothiocyanates: Focus on glucoraphanin
by: Donato Angelino, et al.
Published: (2014-03-01) -
Factors Influencing Glucoraphanin and Sulforaphane Formation in Brassica Plants: A Review
by: Zhen-xin GU, et al.
Published: (2012-11-01) -
Influence of sequential exogenous pretreatment and contact ultrasound-assisted air drying on the metabolic pathway of glucoraphanin in broccoli florets
by: Beini Liu, et al.
Published: (2022-03-01) -
Fermentation for enhancing the bioconversion of glucoraphanin into sulforaphane and improve the functional attributes of broccoli puree
by: Yan Xue Cai, et al.
Published: (2019-10-01)